The Latest Breaking News from Eli Lilly

When Mounjaro came on the market, TikTok went wild. People with obesity ordered the drug in droves thanks to a coupon that allowed them to access it for just $25 a month. Then the coupon went away, leaving destruction in its wake — and obese patients warring with diabetics. Emily…

Hannah Crabtree got active on Twitter in 2016 to find more people like herself: those with Type 1 diabetes who’d hacked their insulin pumps to automatically adjust the amount of insulin delivered.

Eli Lilly stock dipped Friday after the FDA unexpectedly rejected its request for an accelerated approval of its Alzheimer's treatment.

Eli Lilly shares slipped Friday morning after regulators said they need to see more data on the company’s application for a quick approval of its potential Alzheimer’s disease treatment

California's Attorney General Rob Bonta sued the six major companies that dominate the U.S. insulin market

The Food and Drug Administration expanded the label for Novo Nordisk's oral diabetes medicine, leading NVO stock to jump Friday.

California says it will sue the companies that make and promote much of the nation's insulin

There's a large pipeline of promising yet expensive drugs that could get approved.

Tesla shares fell 12.2% on Tuesday after missing expectations on fourth-quarter deliveries.